Catherine Eva Spear Sells 62,213 Shares of FIGS (NYSE:FIGS) Stock

FIGS, Inc. (NYSE:FIGS) CEO Catherine Eva Spear sold 62,213 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $6.88, for a total transaction of $428,025.44. Following the completion of the sale, the chief executive officer owned 1,907,033 shares in the company, valued at approximately $13,120,387.04. The trade was a 3.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Catherine Eva Spear also recently made the following trade(s):

• On Wednesday, August 13th, Catherine Eva Spear sold 65,866 shares of FIGS stock. The stock was sold at an average price of $6.88, for a total transaction of $453,158.08.

FIGS Stock Down 0.1%

Shares of FIGS stock opened at $7.03 on Wednesday. The company’s fifty day simple moving average is $6.85 and its two-hundred day simple moving average is $5.60. The stock has a market cap of $1.15 billion, a P/E ratio of 175.67, a PEG ratio of 4.51 and a beta of 1.33. FIGS, Inc. has a 52 week low of $3.57 and a 52 week high of $7.54.

FIGS (NYSE:FIGS) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.02 by $0.02. FIGS had a return on equity of 1.84% and a net margin of 1.26%.The company had revenue of $152.64 million during the quarter, compared to analyst estimates of $144.17 million. During the same quarter last year, the business posted $0.01 earnings per share. The firm’s revenue was up 5.8% on a year-over-year basis. On average, analysts anticipate that FIGS, Inc. will post 0.01 EPS for the current fiscal year.

Institutional Trading of FIGS

Several institutional investors and hedge funds have recently modified their holdings of FIGS. Security Benefit Life Insurance Co. KS bought a new stake in shares of FIGS during the first quarter valued at approximately $6,962,000. Bamco Inc. NY raised its stake in shares of FIGS by 2.2% during the second quarter. Bamco Inc. NY now owns 59,974,407 shares of the company’s stock valued at $338,256,000 after acquiring an additional 1,302,823 shares in the last quarter. BNP Paribas Financial Markets raised its stake in shares of FIGS by 2,139.7% during the second quarter. BNP Paribas Financial Markets now owns 1,307,468 shares of the company’s stock valued at $7,374,000 after acquiring an additional 1,249,091 shares in the last quarter. Ameriprise Financial Inc. raised its stake in shares of FIGS by 9.0% during the second quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock valued at $78,602,000 after acquiring an additional 1,144,962 shares in the last quarter. Finally, Pacer Advisors Inc. bought a new stake in shares of FIGS during the first quarter valued at approximately $4,640,000. Institutional investors own 92.21% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on FIGS. Wall Street Zen cut FIGS from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Telsey Advisory Group reissued a “market perform” rating and issued a $7.00 price objective (up previously from $5.00) on shares of FIGS in a research note on Monday, August 4th. The Goldman Sachs Group upped their target price on FIGS from $3.75 to $4.50 and gave the company a “sell” rating in a research note on Tuesday, July 22nd. Cowen reaffirmed a “hold” rating on shares of FIGS in a research note on Friday, August 8th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of FIGS in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $5.38.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.